United States:
House Overwhelmingly Approves Insurance Antitrust Reform Legislation
To print this article, all you need is to be registered or login on Mondaq.com.
The House of Representatives has approved HR 372, the Competitive Health Insurance Reform
Act of 2017, which would repeal the antitrust exemption for
health insurance companies provided under the McCarran-Ferguson Act
(although the antitrust exemption for certain collaborative
activities between health insurance businesses would be retained).
HR 372 was approved by a vote of 416-7, and now moves to the
Senate.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
